[Thalidomide and thrombosis].
Schmutz
J-L
JL
Barbaud
A
A
Trechot
P
P
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced*
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide